{"pmid":32443962,"title":"How COVID-19 Rapidly Transformed Clinical Practice at the Harold Schnitzer Diabetes Health Center Now and for the Future.","text":["How COVID-19 Rapidly Transformed Clinical Practice at the Harold Schnitzer Diabetes Health Center Now and for the Future.","J Diabetes Sci Technol","Castle, Jessica R","Rocha, Lolis","Ahmann, Andrew","32443962"],"journal":"J Diabetes Sci Technol","authors":["Castle, Jessica R","Rocha, Lolis","Ahmann, Andrew"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32443962","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1177/1932296820929368","keywords":["covid-19","continuous glucose monitoring","novel coronavirus","type 1 diabetes","type 2 diabetes"],"topics":["Prevention"],"weight":1,"_version_":1667600475791294464,"score":9.490897,"similar":[{"pmid":32271125,"pmcid":"PMC7196360","title":"Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management.","text":["Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management.","Metab Syndr Relat Disord","Stoian, Anca Pantea","Banerjee, Yajnavalka","Rizvi, Ali A","Rizzo, Manfredi","32271125"],"journal":"Metab Syndr Relat Disord","authors":["Stoian, Anca Pantea","Banerjee, Yajnavalka","Rizvi, Ali A","Rizzo, Manfredi"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271125","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1089/met.2020.0037","keywords":["covid-19","cardiovascular disease","endothelial dysfunction","insulin resistance","obesity","type 2 diabetes"],"topics":["Prevention"],"weight":1,"_version_":1666138491809955841,"score":90.35913},{"pmid":32429701,"title":"Personal Experience With COVID-19 and Diabetes in the South of France: Technology Facilitates the Management of Diabetes in Disruptive Times.","text":["Personal Experience With COVID-19 and Diabetes in the South of France: Technology Facilitates the Management of Diabetes in Disruptive Times.","We report our experience with COVID-19 epidemic in patients with type 1 diabetes using diabetes technology in the South of France. Use of insulin pumps and continuous glucose monitoring appeared as an effective way to prevent the risk of acute metabolic complications related to the changes of daily life associated with requested confinement . Care by telemedicine was facilitated in these patients who used diabetes technology while structured education delivered during training and support from home care services were helpful to master the disruptive conditions.","J Diabetes Sci Technol","Renard, Eric","32429701"],"abstract":["We report our experience with COVID-19 epidemic in patients with type 1 diabetes using diabetes technology in the South of France. Use of insulin pumps and continuous glucose monitoring appeared as an effective way to prevent the risk of acute metabolic complications related to the changes of daily life associated with requested confinement . Care by telemedicine was facilitated in these patients who used diabetes technology while structured education delivered during training and support from home care services were helpful to master the disruptive conditions."],"journal":"J Diabetes Sci Technol","authors":["Renard, Eric"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32429701","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1177/1932296820929370","keywords":["covid-19","continuous glucose monitoring","diabetes technology","insulin pump","telemedicine"],"locations":["France"],"countries":["France"],"countries_codes":["FRA|France"],"e_drugs":["Glucose"],"topics":["Prevention"],"weight":1,"_version_":1667342288382066688,"score":76.11949},{"pmid":32429702,"title":"Telemedicine Consultations and Diabetes Technology During COVID-19.","text":["Telemedicine Consultations and Diabetes Technology During COVID-19.","J Diabetes Sci Technol","Norgaard, Kirsten","32429702"],"journal":"J Diabetes Sci Technol","authors":["Norgaard, Kirsten"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32429702","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1177/1932296820929378","keywords":["cgm","covid-19","insulin pumps","telemedicine consultations","type 1 diabetes","uploading programs"],"topics":["Prevention"],"weight":1,"_version_":1667342288160817152,"score":75.7034},{"pmid":32475168,"title":"COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.","text":["COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.","J Diabetes Sci Technol","Ceriello, Antonio","Schnell, Oliver","32475168"],"journal":"J Diabetes Sci Technol","authors":["Ceriello, Antonio","Schnell, Oliver"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32475168","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1177/1932296820930025","keywords":["covid-19","sars -cov-2","continuous glucose monitoring","diabetes","glucose variability","intensive care unit","telemedicine"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1668437834945527808,"score":74.816284},{"pmid":32315948,"pmcid":"PMC7153521","title":"Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic?","text":["Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic?","A type 1 diabetes patient experienced remission associated with chloroquine therapy while travelling to a malaria-endemic area. Chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the COVID-19 pandemic. Patients with type 1 diabetes treated with chloroquine should be monitored for hypoglycaemia, even after recovery.","Diabetes Metab Syndr","Baretic, Maja","32315948"],"abstract":["A type 1 diabetes patient experienced remission associated with chloroquine therapy while travelling to a malaria-endemic area. Chloroquine has immunomodulatory and hypoglycaemic effects and may become more frequently used due to the COVID-19 pandemic. Patients with type 1 diabetes treated with chloroquine should be monitored for hypoglycaemia, even after recovery."],"journal":"Diabetes Metab Syndr","authors":["Baretic, Maja"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32315948","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.dsx.2020.04.014","keywords":["chloroquine","hypoglycaemia","remission","type 1 diabetes"],"e_drugs":["Chloroquine"],"topics":["Prevention"],"weight":1,"_version_":1666138493563174913,"score":71.93514}]}